Raymond James Downgrades Dialysis Corp. of America (DCAI) to Market Perform
More News related to DCAI
- Dialysis Corp. of America (DCAI) Reports Inline Q3 EPS of $0.10
- Dialysis Corporation of America Reports Third Quarter 2009 Results
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- Dialysis Corporation of America Announces Third Quarter 2009 Earnings Release Date
- Dialysis Corporation of America (DCAI) Reports In-Line Q2 EPS of $0.07
Raymond James downgrades Dialysis Corp. of America (Nasdaq: DCAI) from Strong Buy to Market Perform.
Shares of Dialysis Corp. are down more than 5% today following Q1 results reported yesterday after the closing bell rang. The stock most recently traded at $4.90.
Click here to see all the analyst upgrades/downgrades specifically for Dialysis Corp.
Dialysis Corporation of America, through its subsidiaries, develops, owns, and operates outpatient kidney dialysis centers in the United States and internationally.
Related Categories
DowngradesStocks Mentioned
+0.08Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
